Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Lackner Eva-Maria |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Wedrich, A; Ivastinovic, D; Pöschl, EM; Schwab, C; Borkenstein, A; Lackner EM; Velikay-Parel, M
Einfluß der Kataraktoperation auf den Glaskörper
25. Innsbrucker Fortbildung für Augenärzte; "Retina-Update 2013"; NOV 9, 2013; Innsbruck, AUSTRIA. 2013.
[Oral Communication]
Ivastinovic, D; Pöschl, EM; Schwab, C; Borkenstein, A; Lackner, EM; Wedrich, A; Velikay-Parel, M
The prevalence of posterior vitreous detachment one year after cataract surgery determined by optical coherence tomography and ultrasound.
Proceedings of the 34th International Congress of Ophthalmology, Alpe Adria. 2012; -34th International Congress of Ophthalmology, Alpe Adria; JUNE 28-30, 2012; Portoroz, SLOVENIA.
[Oral Communication]
Ivastinovic, D; Schwab, Ch; Borkenstein, A; Lackner, EM; Wedrich, A; Velikay-Parel, M
Posterior vitreous detachment after phacoemulsification
Alpe Adria. 2011; -33rd Annual Meeting of the Alpe Adria Association; MAY 13-15, 2011; Trieste, ITALY.
[Oral Communication]
Ivastinovic, D; Schwab, Ch; Borkenstein, A; Lackner, EM; Wedrich, A; Velikay-Parel, M
Veränderungen des vitreo-retinalen Interface nach Phakoemulsifikation
Spektrum der Augenheilkunde. 2011; -ÖOG; JUN 1-4, 2011; Mayrhofen, AUSTRIA.
[Oral Communication]
Lackner, EM; Ivastinovic, D; Borkenstein, A; Ardjomand, N
Influence of applanation tonometry on keratometry values
http://www.escrs.org/vienna2011/programme/free-paper-details.asp?id=9571&day=5. 2011; -XXIX Congress of the ESCRS; Sept 17-21, 2011; Vienna, AUSTRIA.
[Oral Communication]
Judmaier, S; Lackner, EM; Ivastinovic, D; Velikay-Parel, M
Häufigkeit von Nachblutungen nach Silikonölentfernung bei vitrektomierten Patient/innen mit proliferativer diabetischer Retinopathie
Spektrum der Augenheilkunde 2010; 24(2):-51. Tagung der Österreichischen Opthalmologischen Gesellschaft; MAy 13- 15, 2010; Zell am See, AUSTRIA.
[Oral Communication]
Lackner, EM; Mayer, Ch; Wedrich, A
Retinal phototoxicity after phacoemulsification
Proceedings2010; -World Ophthalmology Congress; Jun 5-9, 2010; Berlin, Germany.
[Poster]
Velikay-Parel, M; Ivastinovits, D; Lackner, EM; Wedrich, A
Benefit and drawbacks of vitrectomy in diabetic retinopathy - a review on 30 years experience
Maribor International Ophthalmology Meeting; SEPT 17,2010; Maribor, SLOVENIA. 2010.
[Oral Communication]
Lackner, EM; Mayer, CF; Wedrich, A
Beidseitige Phototoxizität der Retina nach refraktivem Linsenaustausch.
2009; -50. Jahrestagung der Österreichischen Ophtalomolgischen Gesellschaft; MAY 21-23, 2009; Bad Ischl, AUSTRIA.
[Poster]
Lackner, EM; Wackernagel, W; Mayer, CF; Langmann, G; Stepan, V
Von-Hippel-Lindau Syndrom: Systemische Bevacizumab Therapie bei retinalen kapillären Hämangiomen.
2009; -50. Jahrestagung der Österreichischen Ophtalomolgischen Gesellschaft; MAY 21-23, 2009; Bad Ischl, AUSTRIA.
[Poster]
Mayer, CF; Wackernagel, W; Lackner EM; Schneider, M; Haas, A; Weger, M; Langmann, G
Photodynamic therapy for symptomatic circumscribed choroidal hemangioma.
Proceedings2009; -EVER; SEPT 30 - OCT 3, 2009; Portoroz, SLOVENIA.
[Oral Communication]
Mayer, CF; Wackernagel, W; Lackner, EM; Schneider, MR; Haas, A; Weger, M; Langmann, G
Circumscribed choroidal hemangioma treated with photodynamic therapy
2009; -Alpe Adria Congress of Ophtalmology; Nov 13-14, 2009; Graz.
[Oral Communication]
Mayer, CF; Wackernagel, W; Lackner, EM; Weger, M; Haas, A; Langmann, G
Photodynamische Therapie bei symptomatischen umschriebenen Hämangiomen der Aderhaut
2009; -50. Jahrestagung der Österreichisch Ophtalmologischen Gesellschaft; MAY ; Bad Ischl, AUSTRIA.
[Oral Communication]
Wackernagel, W; Lackner, EM; Mayer, CF; Klisovic, D; Singh, AD
Bevacizumab as treatment for radiation induced neovascular complications.
2009; -50. Jahrestagung der Österreichischen Ophtalomolgischen Gesellschaft; MAY 21-23, 2009; Bad Ischl, AUSTRIA.
[Poster]
Wackernagel, W; Mayer, CF; Lackner, EM; Schneider, M; Langmann, G; Unger, F; Kleinert, R
Immunohistochemical findings and proliferation markers in uveal melanomas after gamma-knife radiosurgery
2009; -EVER; SEPT 30-OKT 3, 2009; Portoroz.
[Oral Communication]
Gleixner, K ; Mayerhofer, M ; Vales, A ; Gruze, A ; Lackner ,E ; Pickl ,F ; Sillaber, C ; Zielinski, CC ; Maeda, H ; Valent, P ;
The Hsp32/HO-1-targeted drug SMA-ZnPP inhibits the growth and viability if neoplastic cells and solid tumors and leukemias
Supplement 1212007; -Frühjahrstagung ÖGHO; April 12-14, 2007; Vienna, Austria.
[Oral Communication]
Gleixner, KV ; Mayerhofer, M ; Vales, A ; Gruze, A ; Lackner, E ; Pickl, F ; Sillaber, C ; Zielinski, C ; Maeda, H ; Valent, P ;
The Hsp32/HO-1-targeted drug SMA-ZnPP counteracts the proliferation and viability of neoplastic cells in solid tumors and hematologic neoplasms.
Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 141222007; -ASCO Annual Meeting ; June 2007; Chicago, USA.
Gleixner, KV ; Mayerhofer, M ; Vales, A ; Gruze, A ; Kneidinger, M ; Hörmann, G ; Krauth, M; Kondo, R ; Sonneck, K ; Samorapoompichit, P ; Lackner, E ; Greish, K ; Pickl, WF ; Sillaber, C ; Zielinski, CC ; Maeda, H ; Valent, P ;
Identification of Hsp32 as a novel survival factor in solid tumors and hematologic malignancies: targeting of Hsp32 by styrene maleic acid zinc protoporphyrin (SMA-ZnPP) counteracts proliferation and viability of neoplastic cells.
American Association for Cancer Research Annual Meeting Proceedings, Abstract number 15262007; -AACR Annual Meeting; April 14-18, 2007; Los Angeles, CA.
[Poster]
Lackner, EM ; Kraut, MT ; Kondo, R ; Rebuzzi, L ; Eigenberger, K ; Vales, A ; Kornek, GV ; Zielinski, CC ; Valent, P ;
Targeting of mTOR is associated with decreased VEGF expression and secretion in cancer cells
Breast Cancer Research and Treatment, Vol. 106, Supplement 1, 20072007; -30th Annual San Antonio Breast Cancer Symposium,; December 13-16, 2007; San Antonio, USA.
[Poster]
Lackner, EM ; Krauth, MT ; Kondo, R ; Rebuzzi, L ; Eigenberger, K ; Vales, A ; Kornek, GV ; Zielinski, C ; Valent, P ;
Expression and secretion of VEGF in solid tumor cells is mediated by the mammalian target of rapamycin (mTOR)
Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 141232007; -ASCO Annual Meeting 2007; June 2007; Chicago, USA.
Lackner, EM ; Krauth, MT ; Kondo, R ; Rebuzzi, L ; Eigenberger, K ; Vales, A ; Kornek, GV ; Zielinski, CC ; Valent, P ;
Targeting of mTOR in cancer cells is associated with reduced expression and secretion of VEGF
Supplementheft Zeitschrift ONKOLOGIE - Int. Journal for Cancer Research and Treatment, Vol. 30, Suppl. 3, 2007
2007; -Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; Oktober 5-9, 2007; Basel, Schweiz.
[Poster]
Gleixner, KV ; Mayerhofer, M ; Vales, A ; Gruze, A ; Kneidinger, M ; Hörmann, G ; Krauth, M ; Kondo, R ; Sonneck,K ; Samorapoompichit,P ; Lackner, E ; Greish, K ; Pickl, WF ; Sillaber, C ; Zielinski, CC ; Maeda, H ; Valent, P ;
TargTeting of Heat Shock Protein 32 (Hsp32) in neoplastic cells by styrene maleic acid zinc protoporphyrin (SMA-ZnPP) is associated with reduced growth and induction of apoptosis
Blood (ASH Annual Meeting Abstracts), Nov 2006; 108: 43232006; -ASH Annual Meeting ; DEZ 9-12, 2006; Orlando, Florida, USA.
[Oral Communication]